|
|
|
Volumn 9, Issue 2, 1996, Pages 123-128
|
|
COX-2: Selective inhibitors in clinical trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE;
5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE;
6 (2 CHLOROPHENYL) 4,7,8,10 TETRAHYDRO 9 (4 METHOXYPHENYLCARBAMOYL) 1 METHYLPYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE;
6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE;
AZAPROPAZONE;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DEXAMETHASONE;
FLOSULIDE;
FLURBIPROFEN;
IBUPROFEN;
INDOMETACIN;
ISOENZYME;
KETOPROFEN;
MELOXICAM;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
ANIMAL MODEL;
APOPTOSIS;
ARTHRITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG SELECTIVITY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INFLAMMATION;
LABOR;
NEPHROTOXICITY;
NONHUMAN;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RHEUMATOID ARTHRITIS;
TUMOR;
|
|
EID: 0029991912
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
